Search bioRxiv⌕ Search

Biology subjects

Pourbaghi, M.

Publications and source records attributed to Pourbaghi, M..

2 recordsLinked to original sources

Constrained Generative Design Frameworks For Computational Discovery of Target-Specific DARPin Candidates

Applying unconstrained generative protein models to fixed structural scaffolds can produce systematic design artifacts, including a "Glycine Trap" characterized by the enrichment of glycine at structurally incompatible positions. Furthermore, optimizing sequences against artificial rigid-body docking geometries induces reward-hacking and severe geometric hallucinations. In addition, the highly conserved designed ankyrin repeat protein, or DARPin, scaffold can obscure defects at the engineered binding interface, causing AlphaFold2-Multimer (AF2) to predict nonfunctional protein-target interactions with high confidence. To overcome these limitations, we developed DARPinMPNN, a scaffold-constrained computational pipeline for DARPin candidate discovery. Restricting sequence generation to a validated DARPin design space eliminated these failure modes. A state-aware chimeric multiple sequence alignment strategy was engineered and enabled AlphaFold2-Multimer (AF2) to serve as a high-throughput structural sieve, while AlphaFold 3 (AF3) provided independent structural validation of candidate binders. Using this framework, we identified mesothelin-targeting DARPin candidates with predicted structural confidences (champion ipTM = 0.83) approaching those of a structurally validated picomolar-affinity binder (G3 control, ipTM = 0.89). By revealing extensive discordance between AF2 and AF3 predictions, this work establishes a robust framework for identifying and prioritizing high-confidence DARPin candidates for experimental validation.

bioinformatics↗

Solvent-free Nanoparticle Assembly Protocol (SNAP): one-pot formulation of drug loaded polyester nanoparticles and their vessel size-dependent perivascular transport

This work describes a new approach for rapid and reproducible formulation of drug loaded biodegradable nanoparticles based on polyester copolymers, including poly(lactic acid)-poly(ethylene glycol) (PLA-PEG) and poly(caprolactone)-poly(ethylene glycol) (PCL-PEG). The new approach, termed Solvent-free Nanoparticle Assembly Protocol (SNAP), carries several advantages over conventional polyester formulation strategies, including very rapid formulation (minutes) and the ability to use nanoparticles immediately without lengthy solvent evaporation or washing steps. Altering polyester molecular weight and concentration, alongside the introduction of specific functional groups yielded precise control of nanoparticle properties, including size, shape, surface charge, drug release and loading. We examined loading of multiple therapeutic compounds, including diclofenac, loperamide, bortezomib, CT179, panobinostat, docetaxel, methotrexate, and camptothecin. The SNAP protocol facilitated the rapid production of stable, drug-loaded nanoparticles with a narrow size distribution and generally good drug loading. Using Fluorescence Resonance Energy Transfer (FRET) and size exclusion chromatography (SEC) with a focus on the model agent Rhodamine B, we were able to carefully examine stability of the nanoparticle and assess the distribution of small molecules within the polymer as well as nanoparticle stability. In vivo evaluation of fluorescently labeled nanoparticles using real-time, intravital microscopy showed that, after direct administration to cerebrospinal fluid (CSF) via the intrathecal cisterna magna (IT-CM) route, the dynamic accumulation of nanoparticles within the perivascular space (PVS) depends on the size of the vessel that is imaged. Nanoparticles accumulated steadily within the PVS of large vessels, while accumulating more slowly and exhibiting clearance from medium-sized and smaller vessels over the course of several hours. In sum, these studies present a new platform for facile production of polyester nanoparticles, demonstrate their ability to encapsulate a variety of hydrophobic small molecules, and expand our knowledge on the development of nanocarriers for intrathecal administration. Taken together, these data open new opportunities for development safer and more effective nanoparticle-based therapies.

bioengineering↗